Choose a country to view content specific to your location
Choose a country to view content specific to your location
Myeloperoxidase (MPO) is a peroxidase enzyme and a marker of inflammation and neutrophil activation during strenuous exercise. In addition, it has been implicated in the oxidation of lipids contained in low-density lipoproteins, infiltration of macrophages and neutrophils, formation of unstable coronary plaques, and plaque rupture. MPO is elevated in patients with coronary artery disease and can be a prognostic marker for identifying patients with unstable plaques before complete microvascular obstruction. MPO serves as a risk marker for atherosclerosis and coronary artery disease, predicting the early risk of myocardial infarction. Quantitative assays for MPO are based on the antibody sandwich principle using ELISA or CLIA.
Contact us to learn more about Meridian’s molecular or immunoassay reagent portfolio. We want to hear from you!
Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!
By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Contact Us” page you agree to the transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be governed by our Privacy Statement.
| Type |
|---|
| Format |
| Host/Source |
| Isotype |
| Tested Apps |
| Unit |
| Catalog |
| Buffer |
| Immunogen |
| COFA Description |
| COFA Notes |
| Recombination |
| SDS |
| COA |
| Product Information Sheet |
| Request Sample |
